Premium
In vivo absolute quantification of hepatic γ‐ATP concentration in mice using 31 P MRS at 11.7 T
Author(s) -
Rothe Maik,
Wessel Corinna,
Cames Sandra,
Szendroedi Julia,
Burkart Volker,
Hwang JongHee,
Roden Michael
Publication year - 2021
Publication title -
nmr in biomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 114
eISSN - 1099-1492
pISSN - 0952-3480
DOI - 10.1002/nbm.4422
Subject(s) - in vivo , medicine , endocrinology , nod , fatty liver , coefficient of variation , insulin resistance , chemistry , metabolism , insulin , diabetes mellitus , biology , microbiology and biotechnology , disease , chromatography
Measurement of ATP concentrations and synthesis in humans indicated abnormal hepatic energy metabolism in obesity, non‐alcoholic fatty liver disease (NAFLD) and Type 2 diabetes. Further mechanistic studies on energy metabolism require the detailed phenotyping of specific mouse models. Thus, this study aimed to establish and evaluate a robust and fast single voxel 31 P MRS method to quantify hepatic γ‐ATP concentrations at 11.7 T in three mouse models with different insulin sensitivities and liver fat contents (72‐week‐old C57BL/6 control mice, 72‐week‐old insulin resistant sterol regulatory‐element binding protein‐1c overexpressing (SREBP‐1c + ) mice and 10‐12‐week‐old prediabetic non‐obese diabetic (NOD) mice). Absolute quantification was performed by employing an external reference and a matching replacement ATP phantom with 3D image selected in vivo spectroscopy 31 P MRS. This single voxel 31 P MRS method non‐invasively quantified hepatic γ‐ATP within 17 min and the repeatability tests provided a coefficient of variation of 7.8 ± 1.1%. The mean hepatic γ‐ATP concentrations were markedly lower in SREBP‐1c + mice (1.14 ± 0.10 mM) than in C57BL/6 mice (2.15 ± 0.13 mM; p < 0.0002) and NOD mice (1.78 ± 0.13 mM; p < 0.006, one‐way ANOVA test). In conclusion, this method allows us to rapidly and precisely measure hepatic γ‐ATP concentrations, and thereby to non‐invasively detect abnormal hepatic energy metabolism in mice with different degrees of insulin resistance and NAFLD. Thus, this 31 P MRS will also be useful for future mechanistic as well as therapeutic translational studies in other murine models.